SCHEMBL7674618

SCHEMBL7674618

CN1CCN(Cc2[c]nccc2N2CCOCC2)CC1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 1/20 0.37
▸ PIK3CA P42336 9/20 0.36
▸ PIK3CB P42338 4/20 0.36
▸ PIK3CD O00329 3/20 0.36
▸ ATR Q13535 1/20 0.36
▸ ATRIP Q8WXE1 1/20 0.36
▸ MC4R P32245 1/20 0.36
▸ PIK3R1 P27986 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ CXCR4 P61073 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ HRH4 Q9H3N8 1/20 0.34
▸ CHKA P35790 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ AKT1 P31749 2/20 0.34
▸ PIK3CG P48736 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14938652 0.75 CYP2A13 (0.47) HRH3CXCR4LMNAL3MBTL1
SCHEMBL3546491 0.69 PIK3CD (0.41) PIK3CAPIK3CBPIK3CDKDM4ELMNA
SCHEMBL3548595 0.69 SMN1; SMN2 (0.44) PIK3CAPIK3CBPIK3CDKDM4ENPSR1
SCHEMBL7678947 0.67 NPSR1 (0.43) HRH3PIK3CAPIK3CBPIK3CDMC4R
SCHEMBL15100913 0.67 MGLL (0.62) KDM4ELMNACHKA
SCHEMBL15100829 0.67 MGLL (0.57) HRH3KDM4ETDP1NPSR1HRH4
SCHEMBL7681827 0.67 PIK3CA (0.47) HRH3PIK3CAATRATRIPMC4R
SCHEMBL17493416 0.66 PDE10A (0.40) PIK3CAPIK3CBPIK3CDATRATRIP
SCHEMBL3763677 0.65 PDE4A (0.46) KDM4ELMNANPSR1
SCHEMBL14355869 0.65 CYP2A13 (0.58) HRH3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6455520-B1 TUMOR NECROSIS FACTOR AND INTERLEUKIN INHIBITORS; ANTIINFLAMMATORY AGENTS, ANTIALLERGENS; BONE DISORDERS ASTRA ZENECA AB (SE) 2002-09-24 — — US disclosed
Send feedback